Explainable Insulin Decision-making System to Assist Physicians in Diabetes Management
NCT ID: NCT06434584
Last Updated: 2024-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
48 participants
OBSERVATIONAL
2022-12-10
2023-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients
NCT04642378
Artificial Intelligence Assisted Insulin Titration System
NCT04053959
Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards
NCT06319300
Insulin Titration System Based on Deep Learning
NCT05409391
Managing Insulin With a Voice AI
NCT05081011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
senior doctor group
without AI assistance
provide insulin dosage and confidence score without AI assistance
with AI dosage assistance
provide insulin dosage and confidence score with AI dosage assistance
with explainable AI assistance
provide insulin dosage and confidence score with explainable AI assistance
with faulty explainable AI assistance
provide insulin dosage and confidence score with faulty explainable AI assistance
junior doctor group
without AI assistance
provide insulin dosage and confidence score without AI assistance
with AI dosage assistance
provide insulin dosage and confidence score with AI dosage assistance
with explainable AI assistance
provide insulin dosage and confidence score with explainable AI assistance
with faulty explainable AI assistance
provide insulin dosage and confidence score with faulty explainable AI assistance
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
without AI assistance
provide insulin dosage and confidence score without AI assistance
with AI dosage assistance
provide insulin dosage and confidence score with AI dosage assistance
with explainable AI assistance
provide insulin dosage and confidence score with explainable AI assistance
with faulty explainable AI assistance
provide insulin dosage and confidence score with faulty explainable AI assistance
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Insulin regimen is one of the following: a. Basal regimen: once a day subcutaneous injection of long-acting or ultra-long-acting insulin; b. Premixed regimen: two/three times a day subcutaneous injection of premixed insulin; c. Basal mealtime regimen: three times a day before meals subcutaneous injection of short-acting or rapid-acting insulin, plus once a day injection of long-acting or ultra-long-acting insulin.
licensed medical practitioner.
Exclusion Criteria
Doctor
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiaoying Li, Professor
Role: STUDY_CHAIR
Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiaoying Li
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20240218043800077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.